Correspondence 0001213900-24-055791 from Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc.
Date: June 25, 2024 · CIK: 0001704287 · Accession: 0001213900-24-055791
AI Filing Summary & Sentiment
File numbers found in text: 333-280253
Show Raw Text
CORRESP
1
filename1.htm
June 25, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: Bluejay Diagnostics, Inc. (CIK: 0001704287)
Registration Statement No.
333-280253 on Form S-1 (the “Registration Statement”)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules
and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities
Act”), Aegis Capital Corp. hereby requests acceleration of the effective date of the above-referenced Registration
Statement so that it will become effective at 4:30 p.m. Eastern Time, June 26, 2024, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act,
please be advised that we will distribute as many electronic copies of the proposed form of preliminary prospectus as appears to be reasonable
to secure adequate distribution.
By: AEGIS CAPITAL CORP.
By:
/s/ Robert Eide
Name:
Robert Eide
Title:
Chief Executive Officer